Acute lymphoblastic leukaemia: diagnosis and classification.

Acute lymphoblastic leukaemia (ALL) is a heterogeneous disease with distinct biological and prognostic groupings. Diagnosis relies on traditional cytomorphological and immunohistochemical evaluation of the leukaemic blasts. Subsequently, cytogenetic analysis identifies clonal numeric and/or structural chromosomal abnormalities that may be present, thus confirming the subtype classification and providing important prognostic information for treatment planning. The major chromosomal abnormalities in ALL are t(9;22)(q34;q11), t(12;21)(p13;q22), t(4;11)(q21;q23), t(1;19)(q23;p13), 8q24 translocations and hyperdiploidy. Generally, hyperdiploidy, occurring most frequently in paediatric cases, is associated with a good prognosis, while hypodiploidy confers a poor prognosis. Among structural chromosomal abnormalities, the t(9;22)(q34;q11) resulting in the BCR/ABL fusion protein, and rearrangements of the MLL gene, confer a poor prognosis in both children and adults, while t(12;21)(p13;q22), resulting in the TEL/AML1 fusion protein, and del (12p) confer a good prognosis. More recently, additional diagnostic and prognostic information has been gained from fluorescence in situ hybridization (FISH) and DNA microarray techniques.

[1]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[2]  Maria Grazia Valsecchi,et al.  Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials , 1997 .

[3]  S. Richards,et al.  Blast cell vacuoles in childhood lymphoblastic leukaemia , 1988, British journal of haematology.

[4]  B. Bain,et al.  Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. , 2002, Clinical and laboratory haematology.

[5]  W. Hiddemann,et al.  Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. , 2000, Blood.

[6]  O. Eden,et al.  Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI) , 1998, Leukemia.

[7]  G. Dizikes,et al.  Acute lymphoblastic leukemia-hand mirror variant. Analysis for endogenous retroviral antibodies in bone marrow plasma. , 1989, American journal of clinical pathology.

[8]  R. Larson,et al.  Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia. , 1996, Leukemia.

[9]  G. Klein.  Immunoglobulin gene associated chromosomal translocations in B-cell derived tumors. , 1999, Current topics in microbiology and immunology.

[10]  G. Rosenberger,et al.  The MYC dualism in growth and death. , 1999, Mutation research.

[11]  P. Polak,et al.  EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein. , 2001, Blood.

[12]  D. Catovsky,et al.  Definition of acute biphenotypic leukemia. , 1997, Haematologica.

[13]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[14]  H. Cavé,et al.  Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia , 1998 .

[15]  M. Greaves,et al.  A natural history for pediatric acute leukemia. , 1993, Blood.

[16]  M. M. Reid,et al.  Bone marrow fibrosis in childhood acute lymphoblastic leukaemia. , 1989, Journal of clinical pathology.

[17]  Hall,et al.  Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA , 1997, British journal of haematology.

[18]  F. Mittelman.  The Third International Workshop on Chromosomes in Leukemia. Lund, Sweden, July 21-25, 1980. Introduction. , 1981, Cancer genetics and cytogenetics.

[19]  Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood , 1998 .

[20]  S. Devesa,et al.  Patterns of occurrence of the leukaemias. , 1995, European journal of cancer.

[21]  H. Gralnick,et al.  The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations , 1981, British journal of haematology.

[22]  S. Raimondi,et al.  Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation. , 1999, Blood.

[23]  H P Koeffler,et al.  TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. , 1996, Blood.

[24]  M. Ehrenfeld,et al.  Rheumatic Manifestations Preceding Adult Acute Leukemia: Characteristics and Implication in Course and Prognosis , 1999, Acta Haematologica.

[25]  M. Kamps.  E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation. , 1997, Current topics in microbiology and immunology.

[26]  A. Ferrando,et al.  Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. , 2000, Seminars in hematology.

[27]  W. Kamps,et al.  Regenerating normal B‐cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease , 2000, British journal of haematology.

[28]  J. Downing,et al.  Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features. , 1995, Blood.

[29]  M. Tomonaga,et al.  Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  C. Sawyers,et al.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. , 2001, The New England journal of medicine.

[31]  C. Schiffer,et al.  Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. , 1993, Journal of the National Cancer Institute.

[32]  C. Bloomfield,et al.  Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. , 1999, Blood.

[33]  M. Andersen,et al.  Therapy‐related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992 , 2001, British journal of haematology.

[34]  H. Dohy,et al.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. , 1994, Radiation research.

[35]  J. Lilleyman,et al.  Granular acute lymphoblastic leukaemia of childhood: a morphological phenomenon. , 1987, Journal of clinical pathology.

[36]  L. Rimsza,et al.  Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. , 2000, American journal of clinical pathology.

[37]  Hyperdiploid (47-50) acute lymphoblastic leukemia in children. , 1992 .

[38]  S. Levitt,et al.  Extramedullary involvement of the testes in childhood leukemia , 1975, Cancer.

[39]  T. McConnell,et al.  Hematogones: a multiparameter analysis of bone marrow precursor cells. , 1989, Blood.

[40]  F. Behm,et al.  Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. , 1996, Leukemia.

[41]  R. Price,et al.  The central nervous system in childhood leukemia: I. The arachnoid , 1973, Cancer.

[42]  N. Heerema,et al.  Clinical Significance of Deletions of Chromosome Arm 6q in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group , 2000, Leukemia & lymphoma.

[43]  F. Behm,et al.  Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. , 1990, Blood.

[44]  G. Morgan,et al.  Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. , 2002, Blood.

[45]  S. Shim,et al.  Acute lymphoblastic leukemia with maturation–a new entity with clinical significance , 1998, Leukemia.

[46]  E. Thiel,et al.  Morphological and cytochemical findings in 150 cases of T‐lineage acute lymphoblastic leukaemia in adults , 1997, British journal of haematology.

[47]  N. Heerema,et al.  Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. , 1999, Blood.

[48]  P. Burton,et al.  Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome. , 1997, Blood.

[49]  J. Rowley,et al.  The critical role of chromosome translocations in human leukemias. , 1998, Annual review of genetics.

[50]  Y. Ben-David,et al.  Friend virus-induced erythroleukemia and the multistage nature of cancer , 1991, Cell.

[51]  E. Thiel,et al.  Improved outcome in adult B-cell acute lymphoblastic leukemia. , 1996, Blood.

[52]  C. Bloomfield,et al.  Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364. , 1999, Blood.

[53]  Z. Estrov,et al.  Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. , 1998, Blood.

[54]  L. Frankel,et al.  Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  R. Wegelius.  Preleukaemic states in children. , 2009, Scandinavian journal of haematology. Supplementum.

[56]  T. Golub,et al.  Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. , 1998, Blood.

[57]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[58]  T. Lipp,et al.  Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. , 2002, Blood.

[59]  S. Raimondi,et al.  Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia. , 1989, Blood.

[60]  C. Pui,et al.  Vertebral compression fracture as a presenting feature of acute lymphoblastic leukemia in children , 1988, Cancer.

[61]  O. Bernard,et al.  TEL-JAK2 transgenic mice develop T-cell leukemia. , 2000, Blood.

[62]  J. Downing,et al.  TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  N. Heerema,et al.  Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  G. Tauro,et al.  Acute lymphocytic leukemia in children presenting with bone marrow necrosis , 1986, American journal of hematology.

[65]  M. Greaves.  Science, medicine, and the future: Childhood leukaemia , 2002 .

[66]  C. Sebban,et al.  Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. , 2000, Hematology/oncology clinics of North America.

[67]  S. Pileri,et al.  Acute leukaemia immunophenotyping in bone‐marrow routine sections , 1999, British journal of haematology.

[68]  S. Ibrahim,et al.  Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease. , 2000, Hematology/oncology clinics of North America.

[69]  J. Downing,et al.  Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study. , 1997, Blood.

[70]  Denis R. Miller,et al.  Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure , 1991, Cancer.

[71]  P S Gaynon,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group , 2016 .

[72]  C. Sawyers,et al.  Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.

[73]  K.,et al.  Surface immunoglobulin light chain-positive acute lymphoblastic leukemia of FAB L1 or L2 type: a report of 6 cases in adults. , 1998, American journal of clinical pathology.

[74]  N. Heerema,et al.  Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. , 1998, Blood.

[75]  R. Larson,et al.  A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. , 1995, Blood.

[76]  J. Niland,et al.  Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia. , 2001, American journal of clinical pathology.

[77]  C. Pui.  Medical progress : childhood leukemias , 1995 .

[78]  M. Slovak,et al.  Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. , 1999, American journal of clinical pathology.

[79]  E. Thiel,et al.  Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. , 1998, Blood.

[80]  D. Hoelzer,et al.  Recent approaches in acute lymphoblastic leukemia in adults. , 2000, Reviews in clinical and experimental hematology.

[81]  F. Behm,et al.  Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. , 1999, Blood.

[82]  Edward J. Lee,et al.  Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  S. Hunger,et al.  Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia. , 1999, Blood.

[84]  J. Downing,et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.

[85]  C. Pui,et al.  Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. , 2000, The New England journal of medicine.

[86]  R. Hoffman,et al.  Hematology: Basic Principles and Practice , 1995 .

[87]  T. Rabbitts,et al.  Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene , 2000, The EMBO journal.

[88]  C. Reynolds,et al.  Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. , 1995, Blood.

[89]  J. Martínez-Climent.  Molecular cytogenetics of childhood hematological malignancies , 1997, Leukemia.

[90]  R Mastrangelo,et al.  Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. , 1986, Medical and pediatric oncology.

[91]  A. Hagemeijer,et al.  Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. , 1992, Leukemia.

[92]  H. Müller-Hermelink,et al.  Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. , 1997, Blood.

[93]  F. Hill,et al.  Morphological heterogeneity in childhood B cell acute lymphoblastic leukaemia. , 1984, Journal of clinical pathology.

[94]  F. Behm,et al.  Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII , 1997, Leukemia.

[95]  L. Skoog,et al.  Diagnosis of lymphoma, leukemia, and metastatic tumor involvement of the cerebrospinal fluid by cytology and immunocytochemistry , 1995, Diagnostic cytopathology.

[96]  A. Órfão,et al.  Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. , 2001, Cytometry.

[97]  H. Prentice,et al.  ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia , 2002, Leukemia.

[98]  G. Gahrton,et al.  6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. , 1998, Blood.

[99]  S. Knuutila,et al.  Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study. , 2001, Medical and pediatric oncology.

[100]  M. Boermeester,et al.  Clinical significance of translocation. , 1994, Gut.

[101]  B. Johansson,et al.  Hematologic malignancies with t(4;11)(q21;q23) – a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases , 1998, Leukemia.

[102]  C. Bartram,et al.  The ATM gene and susceptibility to childhood T‐cell acute lymphoblastic leukaemia , 1998, British journal of haematology.